menu
    • menu

    Company profile for SFJ Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SFJ Pharmaceuticals® is a global specialty pharmaceutical company with an innovative pharmaceutical co-development model that provides an advantageous alternative to traditional pharma partnerships. SFJ Pharmaceuticals®’s unique partnering approach provides experienced clinical and medical professionals, clinical development resources and operational oversight and execution to accelerate late-phase drug development candida...
    SFJ Pharmaceuticals® is a global specialty pharmaceutical company with an innovative pharmaceutical co-development model that provides an advantageous alternative to traditional pharma partnerships. SFJ Pharmaceuticals®’s unique partnering approach provides experienced clinical and medical professionals, clinical development resources and operational oversight and execution to accelerate late-phase drug development candidates across multiple indications and therapeutic areas. The result is pipeline acceleration for our partners.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SFJ PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5000 Hopyard Road Suite 330 Pleasanton, CA
    Telephone
    Telephone
    +1-925.223.6233
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sfj-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sfj-pharmaceuticals-inc./about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apellis's Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit
    Apellis's Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit

    14 May 2024

    // PRESS RELEASE

    https://investors.apellis.com/news-releases/news-release-details/apellis-pharmaceuticals-refinances-existing-debt-475-million-non

    PRESS RELEASE
    14 May 2024
    Share Share
    Serb Pharmaceutical Acquires Rights to SFJ's Bentracimab
    Serb Pharmaceutical Acquires Rights to SFJ's Bentracimab

    11 May 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-05-11/serb-pharmaceutical-acquires-rights-to-sfjs-bentracimab/?widget=listSection

    CONTRACT PHARMA
    11 May 2023
    Share Share
    Bankrupt PhaseBio settles with investor-partner, handing off late-stage drug
    Bankrupt PhaseBio settles with investor-partner, handing off late-stage drug

    18 Jan 2023

    // Amber Tong ENDPTS

    https://endpts.com/phasebio-settles-with-sfj-bankrupt-bentracimab/

    Amber Tong ENDPTS
    18 Jan 2023
    Share Share
    SFJ Pharma Announces Closing of Transfer of Bentracimab Assets from PhaseBio
    SFJ Pharma Announces Closing of Transfer of Bentracimab Assets from PhaseBio

    17 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230117005820/en

    BUSINESSWIRE
    17 Jan 2023
    Share Share
    SFJ plays hardball, demands rights to PhaseBio's lead candidate
    SFJ plays hardball, demands rights to PhaseBio's lead candidate

    28 Sep 2022

    // ENDPTS

    https://endpts.com/sfj-plays-hardball-demands-rights-to-phasebios-lead-candidate/

    ENDPTS
    28 Sep 2022
    Share Share
    PhaseBio and SFJ Announce Approval of IND Application in China for Bentracimab
    PhaseBio and SFJ Announce Approval of IND Application in China for Bentracimab

    10 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210810005399/en

    BUSINESSWIRE
    10 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search